High-dose gabapentin and amitriptyline in the treatment of refractory chemotherapy-induced peripheral neuropathy in a toddler

Pharmacologic management of chemotherapy-induced peripheral neuropathy (CIPN) in pediatric patients remains a challenge. Without effective treatment to control pain from CIPN in children, reduction or discontinuation of life-saving chemotherapeutic medications may be required.